Loading clinical trials...
Loading clinical trials...
A Bioequivalence Study of Capecitabine Tablets in Patients of Locally Advanced or Metastatic Breast Cancer or Metastatic Colorectal Cancer
Conditions
Interventions
Capecitabine tablets
XELODA
Locations
1
China
First Affiliated Hospital of Fourth Military Medical University
Xi’an, Shanxi, China
Start Date
December 1, 2012
Primary Completion Date
June 1, 2013
Completion Date
June 1, 2013
Last Updated
October 1, 2013
Lead Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions